MedicX Fund (LON:MXF) - Momentum building
Jun 06th 2012 - Edison Investment Research today published a report on MedicX Fund (MXF.L, LSE:MXF, LON:MXF) entitled "Momentum Building". In summary, the report says:
MedicX has funds in place for acquisitions and NHS reform, now law, provides further impetus for investment as it pushes decisions on budgets towards GPs and primary care. Higher than anticipated acquisitions put the group on track to exceed our previous full-year portfolio growth targets, with undrawn debt and equity in place for earnings accretive growth. H1 rents were 17% up y o y, due to additions to the portfolio and reviews at 3.2% pa on assets reviewed in the period. Eleven properties were acquired in H1 (a £46m commitment), ahead of our previous £60m pa portfolio growth target. Another four assets (£13.9m) are already approved for acquisition. Behind this is a potential acquisition pipeline of 47 assets totalling £135m,...
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »
